News | August 04, 2008

New GE CT Scanner Technology Captures Rodent Heart Beat at 600 Beats-Per-Minute

August 5, 2008 - GE Healthcare today released a new pre-clinical computed tomography scanner specifically designed to accelerate research in the areas of cardiac disease and drug development.

The GE eXplore CT 120 scanner is an all-new design based on years of research CT scanner experience, GE officials said. Using X-ray source technology derived from clinical systems, the eXplore CT 120 features 100 times the output of previous GE laboratory research imaging systems. This power enables X-ray exposures fast enough and detailed enough to capture the motion of a beating mouse heart, and brings the power of cardiac CT imaging to a popular mammal used in disease research and drug development.

The power of the new X-ray source also allows for more effective filtering of the X-ray beam, reducing the X-ray dose to the research subject compared to previous scanners, while greatly reducing the scan time.

“Morphological imaging is the key to understanding cardiac kinetics,” said Professor André Constantinesco of Hôpitaux Universitaires de Strasbourg. “This scanner provides us the ability to acquire 4D, high-resolution datasets in living mice, improving our ability to quantify rodent models of cardiac diseases.”

The scanner’s user software is designed for throughput and, with its powerful computing hardware, makes the scanner four times faster than previous designs. Industry-standard DICOM compatibility and an optional analysis workstation assist in timely image analysis and production of research data.

For more information: www.gehealthcare.com


Related Content

News | Cardiovascular Clinical Studies

Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...

Home November 12, 2025
Home
News | Cardiovascular Clinical Studies

Oct. 21, 2025 – AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG ...

Home October 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 25, 2025 — Merck, known as MSD outside of the United States and Canada, has announced that new clinical trial and ...

Home August 25, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 18, 2025 — (Newswise) It’s often mistaken for a heart attack, but Takotsubo cardiomyopathy — previously known as ...

Home August 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 20, 2025 — A major international study published in Atherosclerosis* has found that routinely testing for ...

Home August 20, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 4, 2025 — Marea Therapeutics, Inc., a clinical-stage biotechnology company that develops next-generation medicines ...

Home August 04, 2025
Home
News | Cardiovascular Clinical Studies

July 16, 2025 — Medtronic has announced that the first patient has been enrolled in the PEripheral Onyx Liquid Embolic ...

Home July 22, 2025
Home
News | Cardiovascular Clinical Studies

June 11, 2025 — Bayer and the Broad Institute have have extended their research collaboration of 10 years by an ...

Home June 11, 2025
Home
News | Cardiovascular Clinical Studies

May 27, 2025 — Despite scientific advances in cardiovascular care, people in living in rural areas and other communities ...

Home May 27, 2025
Home
News | Cardiovascular Clinical Studies

May 20, 2025 — Shockwave Medical, Inc., part of Johnson & Johnson MedTechhas announced the 30-day primary endpoint ...

Home May 21, 2025
Home
Subscribe Now